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**Biographical Sketch**

As a doctor and researcher, Ruan Li once held the post of director of Institute for Viral Disease Control and Prevention of Chinese Centre for Disease Control and Prevention and chief of Biotech Center for Virus Disease Emergency. Since 1980, he has focused on the study of heritable variation and immunization of viruses and engaged in the research and development of biological technology including genetically engineered vaccines. In recent years, he was responsible for the monitoring of SARS and prevention and control of poxvirus related diseases such as smallpox and monkeypox. He was also responsible for over 20 research projects sponsored by national science and technology projects, national high-tech research and development plan, major sci-tech project, natural science fund, American NIH, EU and Ministry of Health, amongst others. He established two genetic expression systems using mammalian cells and recombinant vaccinia virus Tiantan strain and successfully researched Hepatitis B genetic engineering vaccine and Phase I clinic trails of five vaccinia recombinant vaccines. He was awarded a certificate of distinguished visiting scientist at Mount Sinai School of Medicine, New York in 1986, a certificate of excellent returned overseas researcher who made outstanding contributions to the state in 1991, a government special allowance in 1991, the National Science Fund for Distinguished Young Scholars (NSFDYS) in 1995, the title of National Expert with Remarkable Contributions in 1996, the first prize of the National Science and Technology Progress in Recombinant Hepatitis B Vaccine Research in 1993 and the second prize of the National Science and Technology Progress in Research and Application of High-Efficiency Expression System Derived from Vaccinia Virus Tiantan Strain. He has also won other four provincial and ministry prizes, was involved in producing over 20 books, applied for 11 patents and published over 200 papers.
